Sun Pharma grants licensing agreement to China Medical System arm for 7 generic products

In June 2019, Sun Pharma had announced collaboration with CMS on two speciality products, Tildrakizumab and Cyclosporine A 0.09% (CsA) eye drops for the Greater China market.

from India Infoline News Service https://ift.tt/2z6AaCt